Nuclea Biotechnologies Obtains $5,479,450 New Round

  • Feed Type
  • Date
    11/2/2010
  • Company Name
    Nuclea Biotechnologies
  • Mailing Address
    105 South Street Pittsfield, MA 01201
  • Company Description
    Nuclea Biotechnologies’ primary mission is to conduct genomic research in the oncology field so as to discover biomarkers and gene or protein expression profiles that are unique to oncologic diseases.
  • Website
    http://www.nucleabiomarkers.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,479,450
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.